SAN DIEGO--(BUSINESS WIRE)--Aethlon Medical, Inc. (OTCBB:AEMD), a pioneer in developing therapeutic devices for infectious disease, disclosed today that Chairman and CEO James A. Joyce has authored a report entitled The Treatment of Dengue Hemorrhagic Fever. The content of the report follows:
